India approves $1.9 billion Agila acquisition

US generics company Mylan wins go-ahead to buy Bangalore-based injectables business from India’s Strides Arcolab.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES